Canada VIVO Cannabis study finds medical cannabis effective in treating anxiety and depression The study was the largest of its kind to date, examining the impact of medical cannabis on anxiety and depression in 7,362 Canadian patients Ryan GarnerJune 7, 2022
Business VIVO Cannabis releases Q1 results, posting $6.9 million in revenue VIVO continues to pursue its international expansion strategy, which now represents more than 50 per cent of its cannabis revenue Ryan GarnerMay 18, 2022